By Eshe Nelson Reporting from London Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue on Wednesday that ...

At CES 2025 earlier this week, Lenovo announced a handful of new Android ... as the tablet is already available for purchase), but there’s a button on the keyboard to directly access them ...

Now that the major talking points around the Legion Go 2 and Legion Go S are out there, however, I wanted to circle back and highlight a bunch of interesting information that the Lenovo Legion ...

Novo Nordisk reported strong data for its next-gen anti-obesity medicine. The Danish company has an excellent weight loss drug pipeline. But it's also diversifying its lineup and offering other ...

LISBON, Jan 31 (Reuters) - U.S. private equity firm Lone Star has told the Portuguese government that it is likely to sell a 25-30% stake in Novo Banco via an initial public offering, rather than ...

Back in 2022, Lenovo previewed a novel laptop sporting ... and when the user pushes a button on the keyboard or waves at the webcam, the flexible screen expands upward to offer 16.7 inches from ...

One of my favorite things to come out of CES 2025 was the spread of SteamOS to other PC gaming handhelds, namely a new version of Lenovo’s Legion Go. On the show floor, PCWorld’s Adam Patrick ...

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with ...

LISBON, Feb 5 (Reuters) - Novo Banco's planned initial public offering would be beneficial for the Portuguese banking sector, Bank of Portugal Governor Mario Centeno said on Wednesday, but he ...

Novo Nordisk (NVO) ended the recent trading session at $84.62, demonstrating a -1.9% swing from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.16%. At the same ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. In the phase 3b ...

The revamped White House Oval Office will once again feature the Diet Coke button that President Trump used to summon sodas during his first term. The famous little red button, hidden inside a ...